摘要
目的探讨心房纤颤患者抗凝治疗的因素，以减少房颤相关性卒中的发生。方法：以248例房颤患者为例，收集抗凝治疗的情况，进行回顾性研究，并寻找影响抗凝治疗的因素。结果：248例房颤患者中，实际进行抗凝治疗的占i0．88％。5年间抗凝治疗率无明显提高，阿司匹林使用率仍然很高为43．53％。结论：多种因素导致目前基层医院使用抗凝药物预防心房纤颤相关性卒中的比例仍偏低。
Objective To investigate the factors of anticoagulation therapy in patients with atrial fibrillation, and to reduce the incidence of atrial fibrillationrelated stroke. Methods：248 cases of patients with atrial fibrillation were collected as an example, the situation of anticoagnlation therapy were collected, and thefactors that affected the anticoagulation therapy were retrospectively studied. Results： In 248 patients with atrial fibrillation, the actual anticoagulant therapyaccounted for 10.88%. There was no significant increase in the rate of anticoagulant therapy during the 5 years, and aspirin use was still 43.53%. Conclusion：Several factors lead to the low proportion of the use of anticoagulant drugs in the prevention of atrial fibrillation in primary hospital.
出处
《世界中医药》
CAS
2016年第B03期416-416,共1页
World Chinese Medicine
关键词
心房纤颤
卒中
抗凝治疗
atrial fibrillation
stroke
anticoagulant therapy
